Deferred Tax Assets, Valuation Allowance of Nu-Med Plus, Inc. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Nu-Med Plus, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • Nu-Med Plus, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $2,266,924, a 3.1% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Nu-Med Plus, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $2,266,924 +$68,345 +3.1% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $2,198,579 +$127,813 +6.2% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $2,070,766 -$2,267 -0.11% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q4 2021 $2,073,033 +$163,365 +8.6% 31 Dec 2021 10-K/A 03 Apr 2023 2022 FY
Q4 2020 $1,909,668 31 Dec 2020 10-K/A 11 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.